C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment

Immunology and Cell Biology

Volumn 92, Issue 7, 2014, Pages 631-639

  Croker, Daniel E ^a   Halai, Reena ^a   Kaeslin, Geraldine ^a   Wende, Elisabeth ^b   Fehlhaber, Beate ^b   Klos, Andreas ^b   Monk, Peter N ^c   Cooper, Matthew A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA ARRESTIN 2; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR 1; COMPLEMENT COMPONENT C5A RECEPTOR 2; G PROTEIN COUPLED RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; UNCLASSIFIED DRUG; BETA ARRESTIN; CHEMOKINE RECEPTOR; GPR77 PROTEIN, HUMAN; PROTEIN BINDING; RETINA S ANTIGEN;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN MULTIMERIZATION;

ARRESTINS; CELL LINE; CELLS, CULTURED; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, CHEMOKINE;

EID: 84906063906     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2014.32     Document Type: Article

References (34)

1. Klos A, Wende E, Wareham KJ, Monk PN. International Union of Pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol Rev 2013; 65: 500-543.
2. Monk PN, Scola AM, Madala P, Fairlie DP. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 2007; 152: 429-448. (Pubitemid 47585036)
3. Halai R, Croker DE, Suen JY, Fairlie DP, Cooper MA. A comparative study of impedance versus optical label-free systems relative to labelled assays in a predominantly Gi coupled GPCR (C5aR) signalling. Biosensors 2012; 2: 273-290.
4. Reis ES, Chen H, Sfyroera G, Monk PN, Kohl J, Ricklin D et al. C5a receptordependent cell activation by physiological concentrations of desarginated C5a: Insights from a novel label-free cellular assay. J Immunol 2012; 189: 4797-4805.
5. Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991; 349: 614-617. (Pubitemid 21912116)
6. Ohno M, Hirata T, Enomoto M, Araki T, Ishimaru H, Takahashi TA. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol 2000; 37: 407-412.
7. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, Mackay CR et al. Functional roles for C5a receptors in sepsis. Nat Med 2008; 14: 551-557. (Pubitemid 351655216)
8. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4: 133-142. (Pubitemid 38209207)
9. Buhl AM, Avdi N, Worthen GS, Johnson GL. Mapping of the C5a receptor signal transduction network in human neutrophils. Proc Natl Acad Sci USA 1994; 91: 9190-9194.
10. Okinaga S, Slattery D, Humbles A, Zsengeller Z, Morteau O, Kinrade MB et al. C5L2, a nonsignaling C5A binding protein. Biochemistry 2003; 42: 9406-9415. (Pubitemid 36959248)
11. Scola AM, Johswich KO, Morgan BP, Klos A, Monk PN. The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol 2009; 46: 1149-1162.
12. Van Lith LH, Oosterom J, Van Elsas A, Zaman GJ. C5a-stimulated recruitment of b-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. J Biomol Screen 2009; 14: 1067-1075.
13. Li R, Coulthard LG, Wu MC, Taylor SM, Woodruff TM. C5L2: A controversial receptor of complement anaphylatoxin, C5a. FASEB J 2013; 27: 855-864.
14. Galliera E, Jala VR, Trent JO, Bonecchi R, Signorelli P, Lefkowitz RJ et al. b-arrestindependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 2004; 279: 25590-25597. (Pubitemid 38756820)
15. Chen N-J, Mirtsos C, Suh D, Lu Y-C, Lin W-J, McKerlie C et al. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007; 446: 203-207. (Pubitemid 46398661)
16. Gao H, Neff TA, Guo R-F, Speyer CL, Sarma JV, Tomlins S et al. Evidence for a functional role of the second C5a receptor C5L2. FASEB J 2005; 19: 1003-1005. (Pubitemid 40827732)
17. Wang R, Lu B, Gerard C, Gerard NP. Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis. J Immunol 2013; 191: 4001-4009.
18. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. b-arrestins and cell signaling. Annu Rev Physiol 2007; 69: 483-510.
19. Fan H, Bitto A, Zingarelli B, Luttrell LM, Borg K, Halushka PV et al. b-arrestin 2 negatively regulates sepsis-induced inflammation. Immunology 2010; 130: 344-351.
20. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol 2010; 6: 587-594.
21. Vischer HF, Watts AO, Nijmeijer S, Leurs R. G protein-coupled receptors: Walking handin-hand, talking hand-in-hand? Br J Pharmacol 2011; 163: 246-260.
22. Floyd DH, Geva A, Bruinsma SP, Overton MC, Blumer KJ, Baranski TJ. C5a receptor oligomerization: II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. J Biol Chem 2003; 278: 35354-35361. (Pubitemid 37102304)
23. Poursharifi P, Lapointe M, Petrin D, Devost D, Gauvreau D, Hebert TE et al. C5L2 and C5aR interaction in adipocytes and macrophages: Insights into adipoimmunology. Cell Signal 2013; 25: 910-918.
24. Huttenrauch F, Pollok-Kopp B, Oppermann MG. Protein-coupled receptor kinases promote phosphorylation and b-arrestin-mediated internalization of CCR5 homo-and hetero-oligomers. J Biol Chem 2005; 280: 37503-37515. (Pubitemid 41642359)
25. Croker DE, Halai R, Fairlie DP, Cooper MA. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Immunol Cell Biol 2013; 91: 625-633.
26. Kocan M, Dalrymple MB, Seeber RM, Feldman BJ, Pfleger KD. Enhanced BRET technology for the monitoring of agonist-induced and agonist-independent interactions between GPCRs and b-arrestins. Front Endocrinol (Lausanne) 2011; 1: 12.
27. Bosmann M, Haggadone MD, Zetoune FS, Sarma JV, Ward PA. The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation. Eur J Immunol 2013; 43: 1907-1913.
28. Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS et al. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem2010; 285: 7633-7644.
29. DeFea K. b-arrestins and heterotrimeric G-proteins: Collaborators and competitors in signal transduction. Br J Pharmacol 2008; 153 (Suppl 1), S298-S309.
30. Cao Q, McIsaac SM, Stadnyk AW. Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway. Am J Physiol Cell Physiol 2012; 302: C1731-C1740.
31. Schraufstatter IU, DiScipio RG, Zhao M, Khaldoyanidi SK. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J Immunol 2009; 182: 3827-3836.
32. Seow V, Lim J, Iyer A, Suen JY, Ariffin JK, Hohenhaus DM et al. Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a. J Immunol 2013; 191: 4308-4316.
33. Wrann CD, Winter SW, Barkhausen T, Hildebrand F, Krettek C, Riedemann NC. Distinct involvement of p38-, ERK1/2 and PKC signaling pathways in C5a-mediated priming of oxidative burst in phagocytic cells. Cell Immunol 2007; 245: 63-69. (Pubitemid 46921168)
34. Verreck FAW, Boer Td, Langenberg DML, Hoeve MA, Kramer M, Vaisberg E et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560-4565. (Pubitemid 38437450)